Blog
PDO, PDLA and PCL: how aesthetic polymers differ
These biodegradable polymers are often grouped together, but their structure, persistence and clinical roles are different. Understanding the material helps explain why treatment plans differ.
Biodegradable polymers are used in sutures, threads and injectable collagen-stimulating treatments. The acronyms can sound interchangeable, but each material behaves differently in tissue.
Why the material matters
A polymer's degradation profile, physical structure and intended placement influence how long it persists and what biological response is expected. A thread designed for mechanical support is not the same treatment as an injectable biostimulator, even if both are described as “collagen stimulating”.
One property unites all three and deserves stating plainly at the outset: none of them can be dissolved. Hyaluronic acid fillers can be reversed with hyaluronidase if a problem arises, which is a genuine safety margin. Biodegradable polymers have to be waited out or managed, and that difference should carry weight when choosing between categories rather than being discovered afterwards.
Patients benefit from understanding whether a treatment is providing mechanical support, temporary volume, tissue hydration or a collagen-remodelling stimulus.
PDO: a familiar biodegradable suture polymer
Polydioxanone has a long history in absorbable sutures and is also used in aesthetic threads and selected injectable products. In thread treatments, the material can provide temporary mechanical support while the tissue response develops around it.
Its long surgical track record is a genuine reassurance about the material itself. It is worth noting, though, that a material being well established in sutures does not automatically validate every aesthetic application of it — the placement, form and purpose differ.
PDLA and related lactic-acid polymers
Poly-D-lactic acid and related PLA materials are used in biodegradable medical applications and aesthetic biostimulation. In injectables, the goal is generally not to behave like a conventional hyaluronic-acid filler but to encourage a gradual tissue response over time.
Because collagen remodelling develops progressively, results are usually assessed over months rather than immediately after treatment. This is the source of a common and avoidable error: judging the result at two weeks, concluding nothing happened, and requesting more product before the first treatment has finished working. Over-treatment with biostimulators is considerably harder to correct than under-treatment.
PCL: longer-lasting structural biostimulation
Polycaprolactone is another biodegradable polymer used in medical devices and selected aesthetic injectables. PCL-based formulations can combine an immediate carrier effect with a longer-term collagen response, depending on the product.
Persistence
PCL generally degrades more slowly than PDO, though exact duration depends on the formulation.
Purpose
Often used where tissue quality and structural support are part of the treatment objective.
Planning
Because biostimulatory materials are not simply dissolved like HA fillers, conservative anatomical planning is important.
Longer persistence is not automatically an advantage. It means a good result lasts longer, and it equally means an unsatisfactory one does too. For a first treatment, or in an anatomically demanding area, a shorter-acting material can be the more sensible choice precisely because it is less committing.
The materials side by side
| Material | Typical form | Main mechanism | Onset | Reversible? |
|---|---|---|---|---|
| PDO | Threads, some injectables | Mechanical support plus tissue response | Immediate lift, then gradual | No |
| PDLA / PLLA | Injectable biostimulator | Gradual collagen stimulation | Weeks to months | No |
| PCL | Injectable biostimulator | Carrier effect plus longer collagen response | Immediate then gradual | No |
| CaHA | Injectable | Structure plus collagen response | Immediate then gradual | No |
| Hyaluronic acid | Filler or skinbooster | Volume or hydration | Immediate | Yes |
Read the final column across all five rows. It is the most consequential difference between these treatments and the one least often discussed at the point of sale.
Threads and injectables are not the same treatment
Both may use PDO, but they do different things. A thread provides physical repositioning of tissue through a placed structure; an injectable biostimulator provides no mechanical lift and works entirely through the tissue response it provokes.
This distinction matters when someone is told a treatment will “lift”. Threads produce a genuine but modest and temporary repositioning, and they do not substitute for surgery where laxity is significant. An injectable biostimulator improves tissue quality and firmness over time but does not reposition anything. Expecting a facelift result from either is the commonest source of disappointment.
What can go wrong
Routine effects include swelling, bruising, tenderness and temporary irregularity. Specific to these materials, delayed nodules can occur weeks to months after treatment with biostimulators, and threads can occasionally cause palpability, visible dimpling, migration or extrusion.
Because none of these materials can be dissolved, management of a problem involves time, massage, injectable treatment of nodules where appropriate, or occasionally minor procedural removal. That is a very different situation from a hyaluronic acid result that can be reversed within a day.
Blanching, pain disproportionate to the procedure, dusky or mottled skin discolouration, or any visual change requires immediate assessment. This applies to biostimulators as much as to fillers.
How treatment choice is made
The useful question is not “which polymer is best?” but which treatment mechanism best matches the concern. Laxity, volume loss, fine texture and scar remodelling require different approaches.
Questions worth asking before consenting
- Which specific product, and what material is it?
- Is the aim mechanical support, volume, or a collagen response over time?
- When should I judge the result — and when is it too early?
- What happens if I do not like it, given it cannot be dissolved?
- What is the plan if a nodule develops months later?
Collagen biostimulators and thread treatments
Explore the service pages for treatment-specific information.
Collagen biostimulators → Thread lift → Skin boosters → Dermal fillers →
Questions patients ask
Can any of these be dissolved if I dislike the result?
No. Only hyaluronic acid can be reversed with hyaluronidase. Biodegradable polymers must be waited out or managed, which should carry weight when choosing.
Is longer-lasting always better?
No. Longer persistence means a good result lasts, and equally that an unsatisfactory one does. A shorter-acting material can be wiser for a first treatment.
Why has nothing happened two weeks after my biostimulator?
Because collagen remodelling develops over months. Judging early and requesting more product before the first treatment has worked is a common route to over-treatment.
Will a thread lift replace a facelift?
No. Threads produce genuine but modest and temporary repositioning and do not substitute for surgery where laxity is significant.
Do injectable biostimulators lift?
Not mechanically. They improve tissue quality and firmness over time but do not reposition tissue, which threads do to a limited degree.
Is PDO safe given it is used in sutures?
Its surgical track record is reassuring about the material, though that does not automatically validate every aesthetic application, since placement, form and purpose differ.
What is a delayed nodule?
A firm lump appearing weeks to months after a biostimulator. It is uncommon but recognised, and it should be assessed rather than waited out indefinitely.
Can threads move or become visible?
Occasionally. Palpability, dimpling, migration and extrusion are recognised, which is why placement and patient selection matter.
What symptoms are urgent?
Blanching, disproportionate pain, dusky discolouration or any visual change. Seek assessment immediately, and this applies to biostimulators as much as to fillers.
How many sessions will I need?
It depends on the material and goal. What matters more is agreeing when to judge the result, so that further treatment follows assessment rather than impatience.
Which should I choose for skin laxity?
That depends on degree. Mild laxity may respond to biostimulation or energy devices; significant laxity is a structural problem where surgery is the honest answer.
What should I ask before consenting?
The specific product and material, whether the aim is support or a collagen response, when to judge it, and what the plan is if a nodule appears months later.
Sources & further reading
- Dermal Fillers. StatPearls, NCBI Bookshelf.
- Beleznay K, et al. Avoiding and treating blindness from fillers: a review of the world literature.
- Kroumpouzos G, Treacy P. Hyaluronidase for dermal filler complications.
- American Academy of Dermatology. Injectable treatments patient information.
- Product-specific instructions and regulatory indications should be reviewed for the exact material used.
This article is general educational information. Material properties, indications, risks and expected duration vary by product and technique. Biodegradable polymers cannot be dissolved in the way hyaluronic acid can. Content reviewed by the medical team at Aquila Medical Center, Singapore. Last reviewed: 26 August 2026.
Material choice should follow the treatment goal
A clinical assessment can separate the need for hydration, volume, lifting or collagen remodelling — and identify where surgery is the more honest answer.